Oscar Health Plummets 12.7% After Wells Fargo Cuts Rating

Oscar Health, Inc. (NYSE: OSCR) is among the Stocks fell sharply. Do you have any investments?

Oscar Health fell 12.7% over the past week after investors reacted negatively to yet another stock rating cut.

Last week, Wells Fargo adjusted its stock recommendation and price estimate for Oscar Health, Inc. (NYSE:OSCR) down to "underweight" from "equal weight," with the price target set at $10 compared to the previous $16, due to worries over increasing healthcare expenses and insufficient rates for 2025. This updated valuation represented a 30.4% decrease from its most recent closing value of $14.38.

This came after Barclays' initial analysis of Oscar Health, Inc. (NYSE:OSCR) on July 2, where they gave the company an "underweight" designation but set a price forecast above what Wells Fargo had proposed, at $17 per share.

A detailed view of a patient interacting with a medical practitioner, highlighting the organization's dedication to quality patient service.

As per Barclays, their analysis highlighted policy-related uncertainties that might hinder the insurer's aggressive goals for profit margins and expansion.

Oscar Health, Inc. (NYSE:OSCR) has established an objective of achieving over $2.25 in earnings per share by 2027, following changes in management.

Although we recognize both the risks and possibilities associated with OSCR as an investment, we remain confident that certain artificial intelligence stocks may offer better prospects for achieving larger gains in a shorter period. If you're seeking an AI stock that shows more potential than OSCR and offers up to 10,000% growth opportunity, review our analysis on this topic. cheapest AI stock .

READ NEXT: 30 Shares Expected to Multiply Within Three Years and 11 Secret AI Stocks You Can Purchase Immediately .

Disclaimer: None. This article was first published at Insider Monkey .